Ed Allera, Shareholder in the firm’s FDA & Biotechnology section, provides “clear insight” about technology’s influence on the healthcare industry. He discusses different ways technology will control costs and change policy. Ed also considers Dr. Tom Price’s potential impact as the new head of Health and Human Services, and comments on how medical practice today is similar to legal practice a few decades ago. Read Health IT Outcomes’ article “Will Robots Redesign Healthcare Policy?